HomeNewsBusinessStocksAnish Damania bullish on midcap pharma stocks
Trending Topics

Anish Damania bullish on midcap pharma stocks

Anish Damania, CEO of IDFC Securities is bullish on the midcap pharma names.

November 17, 2015 / 12:32 IST
Story continues below Advertisement

Your browser doesn't support HTML5 video.

Anish Damania, CEO of IDFC Securities told CNBC-TV18, "As long as the growth momentum continues in pharma stocks, you have seen that we have more midcap pharmaceutical names in our top buy list than the largecap pharmaceutical names because we feel that there is some more value left and earnings trajectory seems to be quite in favour of some of these midcap pharmaceutical names as well. So, in the pharmaceutical basket while we are neutral rated on the largecap names, we will be more bullish on the midcap names and that is where our overweight in pharmaceutical actually comes from. Within that space of pharmaceutical we like these midcap companies.""Also if you look at the order in which we have put things, you will see a much larger basket in the largecap names, little bit smaller basket in the midcap names and a much smaller basket in the smallcap names. What we are saying at this point of time, when there is some amount of global uncertainty we would prefer to be more in the largecap space than in the midcap. However, as we become a little bit more certain about the earnings growth which we are expecting, we will expand our midcap and the smallcap universe," he added.

first published: Nov 17, 2015 12:32 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!